Adults with obesity and elevated #CRP who receive GLP-1 receptor agonists experience significantly lower all-cause mortality compared with those taking other weight-loss or #diabetes medications.
thecardiologyadvisor.com/new…
#GLP1s
Following a diagnosis of #HeartFailure with reduced ejection fraction, #transgender and #GenderDiverse veterans are less likely to experience ejection fraction improvement than cisgender women.
thecardiologyadvisor.com/new…
The combination of ceiling-suspended and mobile shields provides the most substantial reduction in occupational #radiation exposure during #neuroendovascular procedures.
thecardiologyadvisor.com/new…
At 1 year, patients treated with a 2-Hz #coronary intravascular lithotripsy catheter experienced a low rate of major adverse cardiovascular events.
thecardiologyadvisor.com/new…
#MACE
📢 We're excited to announce that Thomas Nero, MD, host of the Future Pulse Cardiology podcast, has partnered with Cardiology Advisor and Haymarket Media to distribute podcast episodes as part of Haymarket’s Advisor Amplified program!
Learn more here 📍 bit.ly/4BstDQD
Stay ahead of #CKM care with @NACE_CME!
Join the live broadcast on Sat, Oct 24 @ 9AM ET covering 2026 CKM guidelines, obesity, HTN & MASLD/MASH.
Earn up to 4.5 free CME/CE credits.
Register now: bit.ly/4iaE5TL
#Cardiology #FreeCME
Patients with high-risk #diabetes or #atherosclerosis but no prior #stroke or myocardial infarction experience improved overall survival when evolocumab is added to background lipid-lowering therapy.
thecardiologyadvisor.com/new…
124I-evuzamitide #PET detected #CardiacAmyloidosis with 93.5% sensitivity, 86% specificity, and 94.1% negative predictive value.
thecardiologyadvisor.com/new…
Children who experience #StatusEpilepticus after an #IschemicStroke face a substantially higher risk for poor functional outcomes at 1 year compared with those without acute seizures.
thecardiologyadvisor.com/new…
#Dyspnea was reduced in 63.4%, stayed stable or mid-level in 17.4%, and worsened in 19.2% of patients who were hospitalized due to #HeartFailure.
thecardiologyadvisor.com/new…
Global age-standardized #mortality and disability-adjusted life years associated with #myocarditis decreased significantly over a 33-year period.
thecardiologyadvisor.com/new…
At week 52, high‑sensitivity C-reactive protein levels decreased by 6% from baseline in patients treated with 60 mg/kg of #coramitug, compared with a 33% increase in the placebo group.
#CRP
thecardiologyadvisor.com/new…
The median change in estimated #glomerular filtration rate from baseline to day 28 was –7.62 mL/min/1.73 m2 in patients treated with #acoramidis and –0.99 mL/min/1.73 m2 in those given placebo.
thecardiologyadvisor.com/new…
The vast majority of patients with wild-type transthyretin-mediated amyloid #cardiomyopathy had #extracardiac manifestations at baseline.
bit.ly/4s3oYAj
Patients with ATTR-CM who received continuous #vutrisiran treatment experienced reduced all-cause #hospitalizations compared with those who were first given placebo and then vutrisiran.
thecardiologyadvisor.com/new…
The American Heart Association recommends implementing #antithrombotic stewardship programs to optimize guideline-concordant care and minimize adverse drug-related outcomes.
#AHA
thecardiologyadvisor.com/new…
Experts outline the current applications, patient selection criteria, and potential drawbacks of #robotic-assisted #cardiac surgery.
thecardiologyadvisor.com/fea…
Tailored #PhysicalActivity programs that account for a patient's functional capacity and current fitness level can meaningfully improve long-term #cardiovascular health.
Read more about this new scientific statement from @ACCinTouch!
thecardiologyadvisor.com/new…
Adding #vutrisiran to tafamidis was not superior to tafamidis monotherapy in patients with #ATTR-CM, researchers found.
thecardiologyadvisor.com/new…
#Alcohol use disorder and depressive episodes that develop within 3 years of a #traumatic event are significant predictors of major adverse cardiac and #cerebrovascular events in both men and women.
thecardiologyadvisor.com/new…
